Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.

about

Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.

Item

http://www.wikidata.org/entity/Q47988029

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Tumour-infiltrating lymphocyte ...... apy response in breast cancer.

@en

Tumour-infiltrating lymphocytes

@nl

type

Item

label

Tumour-infiltrating lymphocyte ...... apy response in breast cancer.

@en

Tumour-infiltrating lymphocytes

@nl

prefLabel

Tumour-infiltrating lymphocyte ...... apy response in breast cancer.

@en

Tumour-infiltrating lymphocytes

@nl

P1476

Tumour-infiltrating lymphocyte ...... rapy response in breast cancer

@en

P2093

Giampaolo Bianchini

http://www.w3.org/2001/XMLSchema#string

Hiroyoshi Doihara

http://www.w3.org/2001/XMLSchema#string

Junji Matsuoka

http://www.w3.org/2001/XMLSchema#string

Naoki Niikura

http://www.w3.org/2001/XMLSchema#string

Naruto Taira

http://www.w3.org/2001/XMLSchema#string

Shinobu Masuda

http://www.w3.org/2001/XMLSchema#string

Tadahiko Shien

http://www.w3.org/2001/XMLSchema#string

Taeko Mizoo

http://www.w3.org/2001/XMLSchema#string

Takayuki Iwamoto

http://www.w3.org/2001/XMLSchema#string

Takayuki Motoki

http://www.w3.org/2001/XMLSchema#string

P2860

Relevance of tumor-infiltrating lymphocytes in breast cancer

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

How reliable is Ki-67 immunohistochemistry in grade 2 breast carcinomas? A QA study of the Swiss Working Group of Breast- and Gynecopathologists

Prospective Validation of a 21-Gene Expression Assay in Breast Cancer

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors

Economic evaluation of 21-gene reverse transcriptase-polymerase chain reaction assay in lymph-node-negative, estrogen-receptor-positive, early-stage breast cancer in Japan.

Cost-effectiveness analysis of recurrence score-guided treatment using a 21-gene assay in early breast cancer

Prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancers from two phase III randomized adjuvant breast cancer trials: ECOG 2197 and ECOG 1199.

P2888

s10549-017-4502-3

P304

39-47

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10549-017-4502-3

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

167

http://www.w3.org/2001/XMLSchema#string

P50

Mariko Kochi

P577

2017-09-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28905250

http://www.w3.org/2001/XMLSchema#string